Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status

Published:2011-11-26 Issue:1 Volume:6 Page:88-97
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Nielsen Kirsten Vang,Ejlertsen Bent,Møller Susanne,Jensen Maj-Britt,Balslev Eva,Müller Sven,Knoop Ann,Mouridsen Henning T.

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference52 articles.

1. The WSB1 gene is involved in pancreatic cancer progression;Archange;PLoS ONE,2008

2. Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?;Bartlett;Am. J. Clin. Pathol.,2008

3. Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial;Bartlett;J. Clin. Oncol.,2008

4. Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601);Bartlett;Lancet Oncol.,2010

5. HER-2, TOP2A and chromosome 17 alterations in breast cancer;Beser;Pathol. Oncol. Res.,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study;International Journal of Molecular Sciences;2024-04-19

2. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes;International Journal of Molecular Sciences;2021-12-03

3. A careful reassessment of anthracycline use in curable breast cancer;npj Breast Cancer;2021-10-08

4. HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation;Journal of Pathology and Translational Medicine;2020-01-15

5. Centromere 17 copy number gain reflects chromosomal instability in breast cancer;Scientific Reports;2019-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3